Schedule of Pharmaceutical Benefits - 1 February 2019 update

PBAC

1 February 2019 - The February 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The February issue of the Schedule includes a number of new/revised listings:

  • Guselkumab (Tremfya) - new medicine
  • Iron isomaltoside (Monofer) - new formulation
  • Osimertinib mesyate (Tagrisso) - new medicine
  • Tildrakizumab (Ilumya) - new medicine

Read PBS summary of changes



Michael Wonder

Posted by:

Michael Wonder